Ultra‑sodiophilic mixed conductor interphase enabling uniform top deposition for quasi‑solid‑state sodium‑metal batteries
Peer-Reviewed Publication
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Updates every hour. Last Updated: 3-Nov-2026 11:16 ET (3-Nov-2026 16:16 GMT/UTC)
Artificial solid electrolyte interphase offers a promising route to improve the lifespan and safety of quasi-solid-state sodium-metal batteries (QSMBs), yet its limited ion conductivity and the low liquidity of the polymer electrolyte often result in unstable Na plating/stripping kinetics and poor interfacial durability. Herein, we propose a surface-induced “top” Na deposition mechanism facilitated by an ultra-sodiophilic ionic/electronic mixed conductor interphase exhibiting strong Na+ adsorption affinity, which ensures fast and dendrite-free Na anode operation. The embedded Na3Sb alloy phase, featuring high electronic conductivity and strong Na+ adsorption energy, significantly accelerates interfacial ion diffusion and nucleation kinetics, forming a smooth and compact Na deposition layer that facilitates stable solid electrolyte interphase formation and preserves interfacial integrity. Consequently, Na||Na symmetric cells employing a 1, 3-dioxolane-based gel polymer electrolyte deliver an ultra-long-cycling lifespan of 1000 h at 0.5 mA cm−2 with a low overpotential of 40 mV. Moreover, QSMBs incorporating the modified Na anode and Na3V2(PO4)3 cathode demonstrate outstanding cycling stability (74.1% capacity retention after 9000 cycles at 2C) and superior rate capability (91.7 mAh g−1 at 5C). The work provides mechanistic insights and practical strategies for regulating Na deposition, paving the way toward high-performance QSMBs.
The human hand is a dexterous and versatile machine. Scientists have conventionally tried to replicate these traits in robots by copying the biological mechanics of the hand, resulting in complex and difficult-to-control structures. An alternative solution to these challenges was proposed in a new study, published by Wiley in Advanced Science: The BioflexBot, a novel robot that mimics and even exceeds core motions of the hand with a simple design.
Thanks to machine learning, several common and rare skin diseases can now be diagnosed with 98% accuracy in a breakthrough innovation.
Researchers from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC have developed an automated system that uses MRI to measure brain tissue changes in animal models for large, multicenter studies of experimental stroke treatments. By reducing variability among thousands of preclinical research scans from different sources, the automated system has the potential to improve the early-stage evaluation of new therapies. The system was created for the National Institutes of Health-sponsored Stroke Preclinical Assessment Network (SPAN), which tests potential treatments for acute ischemic stroke in coordinated animal studies before the most promising therapies advance toward clinical trials. The Stevens INI serves as the informatics and data core for SPAN. The open-source image analysis pipeline, described in a new study published in Imaging Neuroscience, was tested on scans from more than 2,000 mice and rats at six academic research centers. Its measurements closely matched those made by human experts and helped reduce variability associated with differences in MRI scanners and acquisition environments. Scientists have traditionally measured damage after an experimental stroke by removing the brain, staining tissue sections, and manually outlining injured areas. That process can distort tissue, depends partly on individual judgment, and captures only one point in time. MRI allows researchers to scan the same animal more than once, tracking early injury and swelling as well as tissue loss that develops later. But analyzing thousands of scans collected on different equipment creates another challenge. The scale of SPAN required a method that could process thousands of scans while applying the same rules to every image, regardless of where the data were collected. The pipeline performed about as consistently with a human reviewer as two human reviewers did with each other. The system also reduced variation linked to different scanners and imaging environments, allowing the same analysis approach to work across all six research centers.
For dogs with heart disease, a fraction of a centimeter can make a life-changing difference.
Veterinarians often rely on chest radiographs to monitor subtle changes in heart size that help determine when treatment should begin. But those measurements can vary from one doctor to the next, making it difficult to know whether a dog’s condition is truly changing or whether the difference is simply the result of human interpretation.
Now, researchers at the Texas A&M College of Veterinary Medicine and Biomedical Sciences (VMBS) have shown that an artificial intelligence-powered tool can measure canine heart size on radiographs with accuracy comparable to trained clinicians, potentially helping veterinarians identify disease progression with greater consistency and confidence.
The study, recently published in PLOS ONE, evaluated RadAnalyzer, a web- and smartphone-based application that automatically measures vertebral heart size (VHS) and vertebral left atrial size (VLAS) — two metrics veterinarians use to assess heart enlargement and monitor disease progression.